Roles of adenosine A1 and A(2A) receptors in the expression and development of methamphetamine-induced sensitization

European Journal of Pharmacology

Volumn 388, Issue 3, 2000, Pages 249-254

  Shimazoe, Takao ^a   Yoshimatsu, Akiko ^a   Kawashimo, Atsuko ^a   Watanabe, Shigenori ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Adenosine; Adenosine A(2A) receptor; Adenosine A1 receptor; Methamphetamine; Sensitization

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A1 RECEPTOR; ADENOSINE A1 RECEPTOR AGONIST; ADENOSINE A2A RECEPTOR; ADENOSINE A2A RECEPTOR AGONIST; CYCLOHEXYLADENOSINE; METHAMPHETAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DOSE RESPONSE; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; RAT; SENSITIZATION;

ADENOSINE; ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; MALE; METHAMPHETAMINE; MOTOR ACTIVITY; PHENETHYLAMINES; RATS; RATS, WISTAR; RECEPTORS, PURINERGIC P1;

EID: 0033965840     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00899-7     Document Type: Article

References (32)

1. Alzheimer C., Rohrenbeck J., Ten Bruggencate G. Adenosine depresses induction of LTP at the mossy fiber-CA3 synapse in vitro. Brain Res. 543:1991;163.
2. Arai I., Shimazoe T., Shibata S., Inoue H., Yoshimatsu A., Watanabe S. Enhancement of dopamine release from the striatum through metabotropic glutamate receptor activation in methamphetamine-sensitized rats. Brain Res. 729:1996;277.
3. 1 receptor agonist, on spontaneous and evoked dopamine release in rat neostriatum. Neurosci. Lett. 185:1995;29.
4. Bonci A., Williams J.T. A common mechanism mediates long-term changes in synaptic transmission after chronic cocaine and morphine. Neuron. 16:1996;631.
5. Brundege J.M., Dunwiddie T.V. Modulation of excitatory synaptic transmission by adenosine released from single hippocampal pyramidal neurons. J. Neurosci. 16:1996;5603.
6. Brundege J.M., Dunwiddie T.V. Role of adenosine as a modulator of synaptic activity in the central nervous system. Adv. Pharmacol. (New York). 39:1997;353.
7. Carlezon W.A., Mendrek A., Wise R.A. MK-801 disrupts the expression but not the development of bromocriptine sensitization: a state-dependency interpretation. Synapse. 20:1995;1.
8. De Mendonca A., Almeida T., Bashir Z.I., Ribeiro J.A. Endogenous adenosine attenuates long-term depression and depotentiation in the CA1 region of the rat hippocampus. Neuropharmacology. 36:1997;161.
9. De Mendonca A., Ribeiro J.A. Adenosine and neuronal plasticity. Life Sci. 60:1997;245.
10. Ferré S. Adenosine-dopamine interactions in the ventral striatum. Implications for the treatment of schizophrenia. Psychopharmacology (Berlin). 133:1997;107.
11. 2 receptors in the ventral striopallidal system. Implications for the treatment of schizophrenia. Neuroscience. 63:1994;765.
12. 1 receptor-mediated mechanisms. Eur. J. Neurosci. 8:1996;1545.
13. 2 receptors induces catalepsy. Neurosci. Lett. 130:1991;162.
14. Fredholm B.B., Dunwiddie T.V. How does adenosine inhibit transmitter release? Trends Pharmacol. Sci. 9:1988;130.
15. Higashi H., Inanaga K., Nishi S., Uchimura N. Enhancement of dopamine actions on rat nucleus accumbens neurons in vitro after methamphetamine pre-treatment. J. Physiol. (London). 408:1989;587.
16. G-nitro-L-arginine methyl ester attenuates the maintenance and expression of methamphetamine-induced behavioral sensitization and enhancement of striatal dopamine release. J. Pharmacol. Exp. Ther. 277:1996;1424.
17. 3H]CGS 21680. Eur. J. Pharmacol. 168:1989;243.
18. Karler R., Calder L.D., Bedingfield J.B. A novel nicotinic-cholinergic role in behavioral sensitization to amphetamine-induced stereotypy in mice. Brain Res. 725:1996;192.
19. Kuribara H. Effects of interdose interval on ambulatory sensitization to methamphetamine, cocaine and morphine in mice. Eur. J. Pharmacol. 316:1996;1.
20. 1 agonist-induced behavioral responses in rats. Life Sci. 43:1988;1207.
21. 2 receptors in unilaterally 6-hydroxydopamine-lesioned rats. Eur. J. Pharmacol. 251:1994;21.
22. 1 receptors in rats. NeuroReport. 7:1996;3013.
23. 2 receptors modulate extracellular dopamine levels in rat striatum. Neurosci. Lett. 212:1996;53.
24. 1 agonists in dopamine-denervated rats. Eur. J. Neurosci. 8:1996;1176.
25. Robinson T.E., Camp D.M. Long-lasting effects of escalating doses of D-amphetamine on brain monoamines, amphetamine-induced stereotyped behavior and spontaneous nocturnal locomotion. Pharmacol. Biochem. Behav. 26:1987;821.
26. Rosenberg P.A., Knowles R., Knowles K.P., Li Y. Beta-adrenergic receptor-mediated regulation of extracellular adenosine in cerebral cortex in culture. J. Neurosci. 14:1994;2953.
27. 2 receptor mRNA in the human brain. Neurosci. Lett. 130:1991;177.
28. Schulz E.M., Wright J.W., Harding J.W. Distinctions between stereotyped sniffing and licking in rats with methamphetamine and apomorphine. Pharmacol. Biochem. Behav. 15:1981;521.
29. 2a agonists on amphetamine-induced locomotion and c-Fos in striatum and nucleus accumbens. Brain Res. 707:1996;75.
30. 1 receptors in rat brain membranes. J. Neurochem. 47:1986;88.
31. Wolf M.E., Dahlin S.L., Hu X.T., Xue C.J., White K. Effects of lesions of prefrontal cortex, amygdala, or fornix on behavioral sensitization to amphetamine: comparison with N-methyl-D-aspartate antagonists. Neuroscience. 69:1995;417.
32. Wolf M.E., White F.J., Hu X.T. MK-801 prevents alterations in the mesoaccumbens dopamine system associated with behavioral sensitization to amphetamine. J. Neurosci. 14:1994;1735.